Trials / Active Not Recruiting
Active Not RecruitingNCT05532722
ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
A Study of ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
- Status
- Active Not Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Abcuro, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An open label, ascending dose study for adult subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABC008 | Given subcutaneous injection |
Timeline
- Start date
- 2022-09-28
- Primary completion
- 2025-09-01
- Completion
- 2027-09-01
- First posted
- 2022-09-08
- Last updated
- 2024-10-28
Locations
8 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05532722. Inclusion in this directory is not an endorsement.